Xact Kapitalforvaltning’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Xact Kapitalforvaltning’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	$445K	Hold	7,065	–	–	0.01%	819
2019 Q4	$875K	Buy	7,065 +3,200	+83%	+$286K	0.01%	679
2019 Q3	$256K	Hold	3,865	–	–	﹤0.01%	1286
2019 Q2	$308K	Hold	3,865	–	–	0.01%	1209
2019 Q1	$432K	Sell	3,865 -1,900	-33%	-$208K	0.01%	1010
2018 Q4	$581K	Buy	5,765 +2,400	+71%	+$249K	0.01%	786
2018 Q3	$425K	Hold	3,365	–	–	0.01%	1096
2018 Q2	$282K	Buy	+3,365	New	+$246K	0.01%	1385

Other funds holding ICPT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Xact Kapitalforvaltning's ICPT Position: Q1 2020 in Review

Xact Kapitalforvaltning held its Intercept Pharmaceuticals, Inc. (ICPT) position steady in Q1 2020 at 7,065 shares worth $445K. The position accounts for 0.01% of the portfolio, ranked #819.

Xact Kapitalforvaltning first reported a position in ICPT in Q2 2018 and has held it in 8 quarters since. The position peaked at $875K in Q4 2019. 188 funds tracked by Wall St. Rank hold ICPT as of Q1 2020.

Xact Kapitalforvaltning held 7,065 shares of Intercept Pharmaceuticals, Inc. worth $445K as of Q1 2020.
Xact Kapitalforvaltning left its Intercept Pharmaceuticals, Inc. share count unchanged in Q1 2020.
Intercept Pharmaceuticals, Inc. made up 0.01% of Xact Kapitalforvaltning's portfolio in Q1 2020, its #819 holding.
Xact Kapitalforvaltning first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2018 and has held it in 8 quarters since.
Xact Kapitalforvaltning's Intercept Pharmaceuticals, Inc. position peaked at $875K in Q4 2019.
188 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q1 2020.

Based on Xact Kapitalforvaltning's 13F filing for Q1 2020, filed 14 May 2020.